Phase 2a study assessing safety and efficacy of XW10508
Latest Information Update: 15 Sep 2021
At a glance
- Drugs XW 10508 (Primary)
- Indications Major depressive disorder; Pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors XWPharma
- 15 Sep 2021 New trial record